186 related articles for article (PubMed ID: 19717646)
1. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.
Bartolucci P; El Murr T; Roudot-Thoraval F; Habibi A; Santin A; Renaud B; Noël V; Michel M; Bachir D; Galactéros F; Godeau B
Blood; 2009 Oct; 114(18):3742-7. PubMed ID: 19717646
[TBL] [Abstract][Full Text] [Related]
2. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
3. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
4. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
[TBL] [Abstract][Full Text] [Related]
5. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
[TBL] [Abstract][Full Text] [Related]
6. Is morphine exposure associated with acute chest syndrome in children with vaso-occlusive crisis of sickle cell disease? A 6-year case-crossover study.
Finkelstein Y; Schechter T; Garcia-Bournissen F; Kirby M; Nurmohamed L; Juurlink DN; Blanchette V; Koren G
Clin Ther; 2007 Dec; 29(12):2738-43. PubMed ID: 18201591
[TBL] [Abstract][Full Text] [Related]
7. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
Telen MJ; Wun T; McCavit TL; De Castro LM; Krishnamurti L; Lanzkron S; Hsu LL; Smith WR; Rhee S; Magnani JL; Thackray H
Blood; 2015 Apr; 125(17):2656-64. PubMed ID: 25733584
[TBL] [Abstract][Full Text] [Related]
8. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Parenteral Opioid Dosing in Adult Sickle Cell Disease Patients With Vaso-occlusive Crisis.
Shah SP; Twilla JD; Kemp L; Phelps GL; Reaves A
J Pain Palliat Care Pharmacother; 2018 Dec; 32(4):201-207. PubMed ID: 30896312
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of oral rofecoxib versus intravenous ketoprofen as an adjuvant to PCA morphine after urologic surgery.
Cabrera MC; Schmied S; Derderian T; White PF; Vega R; Santelices E; Verdugo F
Acta Anaesthesiol Scand; 2004 Oct; 48(9):1190-3. PubMed ID: 15352968
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant interventions with opioids for vaso-occlusive crisis in sickle cell disease: A mixed treatment network meta-analysis of randomized controlled clinical trials.
Sridharan K; Sivaramakrishnan G
J Opioid Manag; 2020; 16(4):267-275. PubMed ID: 32885834
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review of l-glutamine for Prevention of Vaso-occlusive Pain Crisis in Patients with Sickle Cell Disease.
Cieri-Hutcherson NE; Hutcherson TC; Conway-Habes EE; Burns BN; White NA
Pharmacotherapy; 2019 Nov; 39(11):1095-1104. PubMed ID: 31505045
[TBL] [Abstract][Full Text] [Related]
13. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
14. Analgesia in children with sickle cell crisis: comparison of intermittent opioids vs. continuous intravenous infusion of morphine and placebo-controlled study of oxygen inhalation.
Robieux IC; Kellner JD; Coppes MJ; Shaw D; Brown E; Good C; O'Brodovich H; Manson D; Olivieri NF; Zipursky A
Pediatr Hematol Oncol; 1992; 9(4):317-26. PubMed ID: 1467165
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.
Gladwin MT; Kato GJ; Weiner D; Onyekwere OC; Dampier C; Hsu L; Hagar RW; Howard T; Nuss R; Okam MM; Tremonti CK; Berman B; Villella A; Krishnamurti L; Lanzkron S; Castro O; Gordeuk VR; Coles WA; Peters-Lawrence M; Nichols J; Hall MK; Hildesheim M; Blackwelder WC; Baldassarre J; Casella JF;
JAMA; 2011 Mar; 305(9):893-902. PubMed ID: 21364138
[TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Dampier CD; Telen MJ; Wun T; Brown RC; Desai P; El Rassi F; Fuh B; Kanter J; Pastore Y; Rothman J; Taylor JG; Readett D; Sivamurthy KM; Tammara B; Tseng LJ; Lozier JN; Thackray H; Magnani JL; Hassell KL;
Blood; 2023 Jan; 141(2):168-179. PubMed ID: 35981565
[TBL] [Abstract][Full Text] [Related]
17. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
Tanabe P; Silva S; Bosworth HB; Crawford R; Paice JA; Richardson LD; Miller CN; Glassberg J
Am J Hematol; 2018 Feb; 93(2):159-168. PubMed ID: 29047145
[TBL] [Abstract][Full Text] [Related]
19. Lactate Dehydrogenase: A Marker of the Severity of Vaso-Occlusive Crisis in Children with Sickle Cell Disease Presenting at the Emergency Department.
García-Morin M; López-Sangüos C; Vázquez P; Alvárez T; Marañón R; Huerta J; Cela E
Hemoglobin; 2016 Nov; 40(6):388-391. PubMed ID: 28361592
[TBL] [Abstract][Full Text] [Related]
20. Successful epidural analgesia for a vaso-occlusive crisis of sickle cell disease during pregnancy: a case report.
Verstraete S; Verstraete R
J Anesth; 2012 Oct; 26(5):783-5. PubMed ID: 22573004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
